Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.

Alimentary pharmacology & therapeutics - 1 Dec 2009

Nguyen M H, Garcia R T, Trinh H N, Nguyen H A, Nguyen K K, Nguyen L H, Levitt B

Abstract excerpt

BACKGROUND: One of the most important factors in treatment failure using nucleos(t)ide analogues in chronic hepatitis B is anti-viral resistance. Primary drug resistance refers to amino acid changes in the hepatitis B virus polymerase/reverse transcriptase (rt) that result in reduced susceptibili...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cross-Sectional Studies
Share to DNA-Directed DNA Polymerase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Prevalence

Share to RNA-Directed DNA Polymerase

Share to Treatment Outcome

Source

Identifiers

PMID: 19785624
DOI: 10.1111/j.1365-2036.2009.04151.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19785624-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.PMID 19785624Read ↗

Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.Semantic proximity Read ↗

Molecular diagnosis and treatment of drug-resistant hepatitis B virus.Semantic proximity Read ↗

Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.Semantic proximity Read ↗

Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.Semantic proximity Read ↗

Viral resistance in hepatitis B: prevalence and management.Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of Hepatitis B Virus in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of HBV in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive PatientsSemantic proximity Read ↗

Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis BSemantic proximity Read ↗

[Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology].Semantic proximity Read ↗

Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.